| Issue |
Section |
Title |
File |
| No 3 (2011) |
GYNECOLOGY. PROBLEM |
Early ovarian cancer: our view of the problem |
(Rus)
|
| No 1 (2010) |
GYNECOLOGY. TREATMENT |
A new view of treatment for ovarian cancer |
(Rus)
|
| No 3 (2010) |
PHARMACOTHERAPY |
Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer |
(Rus)
|
| No 3-4 (2009) |
GYNECOLOGY. NEW TECHNOLOGIES |
TARGET THERAPY FOR DISSEMINATED CANCER OF THE CERVIX UTERI |
(Rus)
|
| Vol 16, No 2 (2020) |
MAMMOLOGY. CLINICAL CASE |
Radio-induced breast angiosarcoma: features of diagnostics and treatment (a clinical case and literature review) |
(Rus)
(Eng)
|
| Vol 17, No 3 (2021) |
GYNECOLOGY. ORIGINAL REPORTS |
Estimating long-term overall survival with olaparib as maintenance therapy in patients with newly diagnosed advanced ovarian cancer with BRCA mutations |
(Rus)
|
| Vol 17, No 4 (2021) |
MAMMOLOGY. ORIGINAL REPORTS |
Clinical and morphological aspects of neoadjuvant chemotherapy efficacy in patients with aggressive luminal HER2-negative breast cancer |
(Rus)
|
| Vol 18, No 4 (2022) |
MAMMOLOGY. ORIGINAL REPORTS |
Association of polymorphic markers of the XRCC1, ERCC5, TP53, CDKN1A1 genes with the survival of patients after platinum-based chemotherapy for triple negative breast cancer |
(Rus)
|
| Vol 20, No 2 (2024) |
MAMMOLOGY. CLINICAL CASE |
There is nothing more obscure than the obvious fact: a case report of breast cancer associated with Peitz–Jeghers syndrome |
(Rus)
|
| Vol 21, No 2 (2025) |
GYNECOLOGY. REVIEWS |
Current approaches to first-line therapy for endometrial cancer: the role of lenvatinib and pembrolizumab combination therapy |
(Rus)
|
| Vol 21, No 4 (2025) |
MAMMOLOGY. REVIEWS |
From clinical trials to routine practice: 7-year results of the monarchE randomized clinical trial and experience with the use of abemaciclib in hormone-dependent, HER2-negative, high-risk, early breast cancer |
(Rus)
|
